Accumulating evidence suggests that SIRT2 might be a critical modulator in the carcinogenesis of pancreatic cancer, particularly through its aberrant expression in both benign and malignant tissues [86]. This evidence concerns the gene SIRT2 and familial pancreatic carcinoma.